Get my own profile
Public access
View all9 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Philippe BeutelsProfessor at Vaccine & Infectious Disease Institute, University of Antwerp, BelgiumVerified email at uantwerpen.be
- Lander WillemUniversity of AntwerpVerified email at uantwerpen.be
- Niel HensProfessor of BiostatisticsVerified email at uhasselt.be
- Frederik VerelstDirector, Vaccines Value Evidence / Health Outcomes, GSKVerified email at gsk.com
- Jan BroeckhoveProfessor em., Dept. of Computer Science, Universiteit AntwerpenVerified email at uantwerpen.be
- Joke BilckeCenter for Health Economics Research and Modeling of Infectious Diseases, University of AntwerpVerified email at uantwerp.be
- Virginia E. PitzerYale School of Public HealthVerified email at yale.edu
- Professor Sir Andrew PollardUniversity of OxfordVerified email at paediatrics.ox.ac.uk
- A. David PaltielYale UniversityVerified email at yale.edu
- Marina AntillonSwiss Tropical and Public Health InstituteVerified email at aya.yale.edu
- Sean StijvenUniversity of AntwerpVerified email at ua.ac.be
- Wim DelvaSACEMA and Dept of Global Health (Stellenbosch Univ) and WimmyVerified email at sun.ac.za
- Diana M HendrickxMicrobiology, Wageningen UR, The NetherlandsVerified email at wur.nl
- David NiyukuriStellenbosch University/Faculty of Medicine and Health SciencesVerified email at sun.ac.za
- Gerrit BeemsterProfessor of Plant Biology, University of AntwerpVerified email at uantwerpen.be
Follow